Viewing data from:

TERBUTALINE SULFATE

ANDA

TERBUTALINE SULFATE | A077152 | LANNETT CO INC

2 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: BRETHINE(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-08-26 | 4 NDCs

Highest NADAC/Unit

$1.02

per ea

Lowest NADAC/Unit

$0.6846

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
00527131801TERBUTALINE SULFATE 2.5 MG TAB	$1.02	EA	Generic	—	2026-08-19
62135052490TERBUTALINE SULFATE 2.5 MG TAB	$1.02	EA	Generic	—	2026-08-19
00527131101TERBUTALINE SULFATE 5 MG TAB	$0.6846	EA	Generic	—	2026-08-19
62135052590TERBUTALINE SULFATE 5 MG TAB	$0.6846	EA	Generic	—	2026-08-19

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain2 active DMFs2 inactive

2 active API suppliers hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

CAMBREX PROFARMACO MILANO SRLTERBUTALINE SULFATE

DMF 119271996

MELODY HEALTHCARE PVT LTDTERBUTALINE SULFATE USP

DMF 265632012

CIPLA LTDInactiveTERBUTALINE SULFATE USP

DMF 80621989

INDUSTRIE CHIMICHE FARMACEUTICHE ITALIANE SPAInactiveTERBUTALINE SULFATE

DMF 90651991

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — 2.5MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Mar 25, 2005

No patent or exclusivity listings for this strength.

#002 — 5MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Mar 25, 2005